山東威高集團醫用高分子製品股份有限公司(01066)于2026年2月23日发布翌日披露报表，披露当日于香港联合交易所回购股份60,000股，占该次回购前已发行股份总数的约0.0013%。每股价格区间为5.23港元至5.24港元，合计支付约31.42万港元。回购完成后，公司已发行股份总数为4,522,332,324股，其中4,480,750,324股为非库藏股，41,582,000股为库藏股。
公司购回授权于2025年5月27日获股东大会通过，可回购股份上限为451,560,392股，截至公告日合计已回购34,933,600股，占授权总数的约7.7362%。公司确认已遵守香港联合交易所有限公司证券上市规则及相关法律规定。本次公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.